PubMed

Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

Hunter SJ, Boyd AC, O'Harte FP, McKillop AM, Wiggam MI, Mooney MH, McCluskey JT, Lindsay JR, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM, Flatt PR.

Diabetes. 2003 Feb;52(2):492-8.PMID: 12540626 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of hepatic insulin action in obese type 2 diabetic patients.

Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.

Diabetes. 2001 Jun;50(6):1363-70.PMID: 11375337 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G.

Diabetes Care. 1995 Feb;18(2):226-33.PMID: 7729302 [PubMed - indexed for MEDLINE]Related articles

Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

Diabetes. 2001 Aug;50(8):1807-12.PMID: 11473042 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.

Diabetes. 2000 Apr;49(4):633-9.PMID: 10871202 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.

Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG.

J Clin Invest. 1984 Mar;73(3):664-72.PMID: 6368585 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue.

Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, Bonora E.

Diabetes Care. 2001 Nov;24(11):1961-6.PMID: 11679465 [PubMed - indexed for MEDLINE]Related articlesFree article

In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

Burén J, Lindmark S, Renström F, Eriksson JW.

Metabolism. 2003 Feb;52(2):239-45.PMID: 12601640 [PubMed - indexed for MEDLINE]Related articles

Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA.

Diabetes. 1999 Aug;48(8):1572-8.PMID: 10426375 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria.

Wiggam MI, Hunter SJ, Ennis CN, Sheridan B, Atkinson AB, Bell PM.

Diabetes Res Clin Pract. 2001 Aug;53(2):73-83.PMID: 11403855 [PubMed - indexed for MEDLINE]Related articles

Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D.

J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M681-5.PMID: 11682575 [PubMed - indexed for MEDLINE]Related articles

Meal-induced 24-hour profile of circulating glycated insulin in type 2 diabetic subjects measured by a novel radioimmunoassay.

Lindsay JR, McKillop AM, Mooney MH, Flatt PR, Bell PM, O'harte FP.

Metabolism. 2003 May;52(5):631-5.PMID: 12759896 [PubMed - indexed for MEDLINE]Related articles

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.

Koopmans SJ, Kushwaha RS, DeFronzo RA.

Metabolism. 1999 Mar;48(3):330-7.PMID: 10094109 [PubMed - indexed for MEDLINE]Related articles

Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article